MedPath

Abcuro, Inc.

Abcuro, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2015-01-01
Employees
1
Market Cap
-
Website
http://www.abcuro.com

Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis

Phase 2
Active, not recruiting
Conditions
Inclusion Body Myositis (IBM)
Interventions
First Posted Date
2024-06-10
Last Posted Date
2024-12-05
Lead Sponsor
Abcuro, Inc.
Target Recruit Count
270
Registration Number
NCT06450886
Locations
🇺🇸

Hospital for Special Surgery, New York, New York, United States

🇦🇺

Royal North Shore Hospital, Saint Leonards, New South Wales, Australia

🇺🇸

Neuromuscular Research Center, Phoenix, Arizona, United States

and more 12 locations

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Phase 2
Active, not recruiting
Conditions
Inclusion Body Myositis
Interventions
First Posted Date
2023-02-10
Last Posted Date
2024-04-05
Lead Sponsor
Abcuro, Inc.
Target Recruit Count
231
Registration Number
NCT05721573
Locations
🇺🇸

UCLA Medical Center, Los Angeles, California, United States

🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 41 locations

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Phase 1
Active, not recruiting
Conditions
T-cell Large Granular Lymphocytic Leukemia
Interventions
First Posted Date
2022-09-08
Last Posted Date
2024-10-28
Lead Sponsor
Abcuro, Inc.
Target Recruit Count
21
Registration Number
NCT05532722
Locations
🇺🇸

City of Hope, Duarte, California, United States

🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

and more 5 locations

A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients with (IBM)

Phase 1
Completed
Conditions
Inclusion Body Myositis
Interventions
First Posted Date
2020-12-09
Last Posted Date
2025-02-20
Lead Sponsor
Abcuro, Inc.
Target Recruit Count
19
Registration Number
NCT04659031
Locations
🇦🇺

Royal North Shore Hospital, Sydney, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

🇦🇺

Royal Brisbane, Herston, Australia

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath